|Articles|October 11, 2011
StudyManager Unveils Reveal Version 3.3
Advertisement
StudyManager
announced the release of
Reveal 3.3
, with enhanced features that provide greater ease of use and performance for research sites, academic medical centers, and hospitals.
Based on customer feedback and StudyManager’s nearly 20 years in the field, Reveal 3.3 offers a number of key ease-of-use and productivity enhancements, including:
- Study budget interface, enabling faster review of budgeted payables.
- A “Next Appointment” feature, which provides at-a-glance patient information, helping coordinators prepare for upcoming appointments.
- A capability allowing users to project and review patient visit “windows," helping to improve protocol compliance.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
5